Table 1 Baseline clinical baseline characteristic of all patients
STEMI group (n = 77) | NSTEMI group (n = 35) | UAP group (n = 83) | Control group (n = 39) | ||
|---|---|---|---|---|---|
Sex | Male | 165 (84.42%)** | 29 (82.86%)** | 57 (68.67%) | 20 (51.28%) |
Female | 412 (15.58%) | 6 (17.14%) | 26 (31.33%) | 19 (48.72%) | |
Age | 59.19 ± 11.76* | 67.14 ± 10.74 | 64.12 ± 10.36 | 64.59 ± 8.14 | |
Hypertension | 42 (54.55%) | 25 (71.43%) | 56 (67.47%) | 23 (58.97%) | |
Diabetes | 20 (25.97%) | 14 (40.00%)* | 25 (30.12%) | 6 (15.38%) | |
LDL-C | 3.11 ± 1.02** | 3.07 ± 0.91* | 2.65 ± 0.98 | 2.60 ± 0.77 | |
Serum creatinine | 74.78 ± 19.63 | 82.05 ± 24.91 | 75.55 ± 18.82 | 75.87 ± 19.73 | |
Cys C | 1.34 ± 0.48 | 1.46 ± 0.58 | 1.26 ± 0.27 | 1.30 ± 0.35 | |
eGFR | 99.47 ± 35.44 | 84.72 ± 35.42 | 83.03 ± 25.02 | 81.44 ± 23.95 | |